Business · Companies · 2 hrs ago
Jubilant Pharmova approves NCD issue of up to ₹800 crore
Jubilant Pharmova has approved plans to raise up to ₹800 crore by issuing non-convertible debentures, or NCDs.
The company is based in India, and the debentures are proposed to be listed on the BSE.
It may issue up to 80,000 debentures, each with a face value of ₹1 lakh, in one or more rounds.
The securities may be secured or unsecured, and their interest rate will be set during bidding.
They can have a term of up to five years from the date they are allotted.
The board also plans to seek shareholder approval to issue private debt securities of up to ₹2,500 crore outstanding at any time over one year.
The proposed issue is subject to applicable laws and regulatory approvals.
Jubilant Pharmova’s board approved an issue of non-convertible debentures worth up to ₹800 crore through private placement.
The proposed issue may include up to 80,000 debentures, each with a face value of ₹1 lakh.
The debentures are proposed to be listed on the BSE and may have a tenure of up to five years.
The interest rate will be determined during the bidding process.
The board also approved seeking shareholder authorisation for private placements of debt securities worth up to ₹2,500 crore outstanding at any time over one year.
- Who
- Jubilant Pharmova Ltd.
- What
- Its board approved a private placement of non-convertible debentures worth up to ₹800 crore.
- When
- The board approved the issue on Monday; the article was published on October 13, 2026.
- Where
- The debentures are proposed to be listed on the BSE.
- Why
- Not stated
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Maximum issue size
- ₹800 crore
- Maximum number of debentures
- 80,000
- Face value per debenture
- ₹1 lakh
- Proposed listing venue
- BSE
- Maximum tenure
- Five years
- Shareholder authorisation sought
- Up to ₹2,500 crore outstanding at any time over one year
Sources
Related news
Mesa School of Business raises Rs 110 crore in co-led funding round
IMF raises India’s growth forecasts to 7% for FY27 and FY28
Indian 10-year bond yields reach highest level since March 2023
Nifty weekly expiry puts 22,250–22,500 range in focus
Clueso raises $10 million in Series A funding
Geojit sees possible rebounds in three Indian stocks
Tonbo Imaging sets ₹665–700 per share price band for ₹852 crore IPO
IMF raises India’s 2026 growth forecast to 7%
Zetwerk targets Rs 5,012 crore IPO
Bank of India reports Rs 575 crore exposure to Future Enterprises as fraud
RBI restricts overseas rupee derivatives and expands 20% cash reserve rule
